# Limited Competition: Research Centers in Minority Institutions (RCMI) Clinical Research Network for Health Equity (UG3/UH3 - Clinical Trial Optional)

Source: https://welltoldgrants.com/grants/rfa-md-22-006-limited-competition-research-centers-in-minority/  
Official notice: https://www.grants.gov/search-results-detail/339292

> National Institutes of Health offered grants of up to $1.0 million to colleges and universities. Applications closed on May 31, 2022.

| Field | Value |
|---|---|
| Opportunity number | RFA-MD-22-006 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | May 31, 2022 |
| Award ceiling | $1.0 million |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.307 |

## Who can apply

- Public and State controlled institutions of higher education
- Private institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) ; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

## What the grant funds

This Funding Opportunity Announcement (FOA) invites applications from current Research Centers in Minority Institutions (RCMI) awardees to participate in the RCMI Clinical Research Network for Health Equity (RCMI-CRNHE), a newly established clinical research network that will transform the development, delivery, and sustainability of evidence-based health care practices and services by providing the infrastructure to leverage community-based clinicians and/or health care delivery systems to conduct research addressing health care for populations that experience health disparities including the diverse clinicians providing health services. The UG3/UH3 Cooperative Agreement involves 2 phases. The UG3 phase, for up to 2 years, is designed to support a project with specific milestones to be accomplished by the end of the period. The UH3 phase is to provide funding for up to 3 additional years following successful completion of the UG3. UG3 projects that meet their milestones will be administratively considered by NIMHD and prioritized for transition to the UH3 phase. Investigators submitting to this FOA must describe both UG3 and UH3 phases.

## Questions people ask

### Is RFA-MD-22-006 still open?

No. It closed on May 31, 2022.

### Who can apply for Limited Competition: Research Centers in Minority Institutions (RCMI) Clinical Research Network for Health Equity (UG3/UH3 - Clinical Trial Optional)?

National Institutes of Health accepted applications from colleges and universities. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Limited Competition: Research Centers in Minority Institutions (RCMI) Clinical Research Network for Health Equity (UG3/UH3 - Clinical Trial Optional)?

Closed May 31, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $1.0 million each.

### Who has been funded under RFA-MD-22-006?

NIH RePORTER lists 6 projects funded under RFA-MD-22-006 in fiscal 2022 to 2026, at 4 institutions. The most were at University of Hawaii at Manoa, San Diego State University, North Carolina Central University.

### Who has won Minority Health and Health Disparities Research  grants before?

The largest recipients over five fiscal years were The Johns Hopkins University, The Trustees of Columbia University in the City of New York, University of Hawaii. The program made 1,237 awards worth $2.0 billion in that time.